Cover Image
市場調查報告書

心律管理設備:醫療設備的開發平台評估

Cardiac Rhythm Management Devices - Medical Devices Pipeline Assessment, 2015

出版商 GlobalData 商品編碼 350911
出版日期 內容資訊 英文 393 Pages
訂單完成後即時交付
價格
Back to Top
心律管理設備:醫療設備的開發平台評估 Cardiac Rhythm Management Devices - Medical Devices Pipeline Assessment, 2015
出版日期: 2016年01月01日 內容資訊: 英文 393 Pages
簡介

本報告提供全球心律管理 (CRM) 設備市場上主要的開發中產品 (醫療設備)與其臨床實驗的進展調查,再彙整產品特性比較分析 (臨床實驗的各進展階段) ,以及主要企業簡介及代表性產品,近來的市場動靜 (資本交易·產業聯盟等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 心律管理設備市場概要

第3章 心律管理設備市場:臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各市場區隔
  • 開發中產品:各地區
  • 開發中產品:法規途徑別
  • 開發中產品:估計認證時期別
  • 開發中產品:現在進行中的臨床實驗

第4章 臨床實驗中的開發中產品:各企業

  • 心律管理設備的企業:各臨床實驗階段的開發中產品
  • 心律管理設備:各臨床實驗階段的開發中產品

第5章 心律管理設備市場:企業·產品概要

  • AI Medical Semiconductor Ltd.
    • 開發中產品及進行中的臨床實驗概要
  • AIS Inc.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Boston TransTec, LLC
  • CardiaLen, Inc.
  • CVRx, Inc.
  • DHS Medical
  • Duke University
  • EBR Systems, Inc.
  • Endurance Rhythm Inc.
  • Greatbatch, Inc.
  • Hadasit Medical Research Services & Development Ltd
  • Impulse Dynamics N.V.
  • Imricor Medical Systems, Inc.
  • InnerPulse, Inc.
  • Kenergy Inc.
  • Krisara Engineering, LLC
  • LifeWave Hi-Tech Medical Devices Ltd.
  • Mathematical Bio-Solutions Inc.
  • Mayo Clinic
  • Medtronic plc
  • MicroPort Scientific Corporation
  • MRI Interventions, Inc
  • NanoLinea
  • NDSU Research Foundation
  • NuVascular Technologies Inc
  • Odem Medical Ltd.
  • Perpetuum Ltd.
  • Queen Mary University of London
  • Rochester Institute of Technology
  • Semprus BioSciences
  • Smartwave Medical Ltd
  • Sorin Group Italia S.r.l
  • Sorin S.p.A. (Inactive)
  • St. Jude Medical, Inc.
  • The Johns Hopkins University
  • The University of Utah
  • TransWorld Med Corporation
  • U.S. Stem Cell, Inc.
  • University of Bern
  • University of California, Los Angeles
  • University of Leicester
  • University of Michigan

第6章 心律管理設備市場:目前的趨勢

第7章 附錄

圖表一覽

目錄
Product Code: GDME0130EPD

GlobalData's Medical Devices sector report, "Cardiac Rhythm Management Devices - Medical Devices Pipeline Assessment, 2015" provides an overview of Cardiac Rhythm Management Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Rhythm Management Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cardiac Rhythm Management Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiac Rhythm Management Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiac Rhythm Management Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Cardiac Rhythm Management Devices Overview

3. Products under Development

  • 3.1. Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development
  • 3.2. Cardiac Rhythm Management Devices - Pipeline Products by Segment
  • 3.3. Cardiac Rhythm Management Devices - Pipeline Products by Territory
  • 3.4. Cardiac Rhythm Management Devices - Pipeline Products by Regulatory Path
  • 3.5. Cardiac Rhythm Management Devices - Pipeline Products by Estimated Approval Date
  • 3.6. Cardiac Rhythm Management Devices - Ongoing Clinical Trials

4. Cardiac Rhythm Management Devices - Pipeline Products under Development by Companies

  • 4.1. Cardiac Rhythm Management Devices Companies - Pipeline Products by Stage of Development
  • 4.2. Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development

5. Cardiac Rhythm Management Devices Companies and Product Overview

  • 5.1. AI Medical Semiconductor Ltd. Company Overview
    • 5.1.1. AI Medical Semiconductor Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. AIS Inc. Company Overview
    • 5.2.1. AIS Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Biotronik SE & Co. KG Company Overview
    • 5.3.1. Biotronik SE & Co. KG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Boston Scientific Corporation Company Overview
    • 5.4.1. Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Boston TransTec, LLC Company Overview
    • 5.5.1. Boston TransTec, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. CardiaLen, Inc. Company Overview
    • 5.6.1. CardiaLen, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. CVRx, Inc. Company Overview
    • 5.7.1. CVRx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. DHS Medical Company Overview
    • 5.8.1. DHS Medical Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Duke University Company Overview
    • 5.9.1. Duke University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. EBR Systems, Inc. Company Overview
    • 5.10.1. EBR Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Endurance Rhythm Inc. Company Overview
    • 5.11.1. Endurance Rhythm Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Greatbatch, Inc. Company Overview
    • 5.12.1. Greatbatch, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Hadasit Medical Research Services & Development Ltd Company Overview
    • 5.13.1. Hadasit Medical Research Services & Development Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. Impulse Dynamics N.V. Company Overview
    • 5.14.1. Impulse Dynamics N.V. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. Imricor Medical Systems, Inc. Company Overview
    • 5.15.1. Imricor Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. InnerPulse, Inc. Company Overview
    • 5.16.1. InnerPulse, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. Kenergy Inc. Company Overview
    • 5.17.1. Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. Krisara Engineering, LLC Company Overview
    • 5.18.1. Krisara Engineering, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. LifeWave Hi-Tech Medical Devices Ltd. Company Overview
    • 5.19.1. LifeWave Hi-Tech Medical Devices Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. Mathematical Bio-Solutions Inc. Company Overview
    • 5.20.1. Mathematical Bio-Solutions Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. Mayo Clinic. Company Overview
    • 5.21.1. Mayo Clinic. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. Medtronic plc Company Overview
    • 5.22.1. Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. MicroPort Scientific Corporation Company Overview
    • 5.23.1. MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. MRI Interventions, Inc Company Overview
    • 5.24.1. MRI Interventions, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25. NanoLinea Company Overview
    • 5.25.1. NanoLinea Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26. NDSU Research Foundation Company Overview
    • 5.26.1. NDSU Research Foundation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27. NuVascular Technologies Inc Company Overview
    • 5.27.1. NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28. Odem Medical Ltd. Company Overview
    • 5.28.1. Odem Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29. Perpetuum Ltd. Company Overview
    • 5.29.1. Perpetuum Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30. Queen Mary University of London Company Overview
    • 5.30.1. Queen Mary University of London Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31. Rochester Institute of Technology Company Overview
    • 5.31.1. Rochester Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32. Semprus BioSciences Company Overview
    • 5.32.1. Semprus BioSciences Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33. Smartwave Medical Ltd Company Overview
    • 5.33.1. Smartwave Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34. Sorin Group Italia S.r.l Company Overview
    • 5.34.1. Sorin Group Italia S.r.l Pipeline Products & Ongoing Clinical Trials Overview
  • 5.35. Sorin S.p.A. (Inactive) Company Overview
    • 5.35.1. Sorin S.p.A. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.36. St. Jude Medical, Inc. Company Overview
    • 5.36.1. St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.37. The Johns Hopkins University Company Overview
    • 5.37.1. The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.38. The University of Utah Company Overview
    • 5.38.1. The University of Utah Pipeline Products & Ongoing Clinical Trials Overview
  • 5.39. TransWorld Med Corporation Company Overview
    • 5.39.1. TransWorld Med Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.40. U.S. Stem Cell, Inc. Company Overview
    • 5.40.1. U.S. Stem Cell, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.41. University of Bern Company Overview
    • 5.41.1. University of Bern Pipeline Products & Ongoing Clinical Trials Overview
  • 5.42. University of California, Los Angeles Company Overview
    • 5.42.1. University of California, Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
  • 5.43. University of Leicester Company Overview
    • 5.43.1. University of Leicester Pipeline Products & Ongoing Clinical Trials Overview
  • 5.44. University of Michigan Company Overview
    • 5.44.1. University of Michigan Pipeline Products & Ongoing Clinical Trials Overview

6. Cardiac Rhythm Management Devices- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development
  • Table 2: Cardiac Rhythm Management Devices - Pipeline Products by Segment
  • Table 3: Cardiac Rhythm Management Devices - Pipeline Products by Territory
  • Table 4: Cardiac Rhythm Management Devices - Pipeline Products by Regulatory Path
  • Table 5: Cardiac Rhythm Management Devices - Pipeline Products by Estimated Approval Date
  • Table 6: Cardiac Rhythm Management Devices - Ongoing Clinical Trials
  • Table 7: Cardiac Rhythm Management Devices Companies - Pipeline Products by Stage of Development
  • Table 8: Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development
  • Table 9: AI Medical Semiconductor Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Adaptive CRT And Vagal Stimulation Device - Product Status
  • Table 11: Adaptive CRT And Vagal Stimulation Device - Product Description
  • Table 12: AIS Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: Guardian - Product Status
  • Table 14: Guardian - Product Description
  • Table 15: Biotronik SE & Co. KG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: ProMRI Iforia 5 HF-T ICD - Product Status
  • Table 17: ProMRI Iforia 5 HF-T ICD - Product Description
  • Table 18: ProMRI Iforia 5 Series DR-T ICD - Product Status
  • Table 19: ProMRI Iforia 5 Series DR-T ICD - Product Description
  • Table 20: ProMRI Iforia 5 VR-T DX ICD - Product Status
  • Table 21: ProMRI Iforia 5 VR-T DX ICD - Product Description
  • Table 22: ProMRI Iforia 5 VR-T ICD - Product Status
  • Table 23: ProMRI Iforia 5 VR-T ICD - Product Description
  • Table 24: ProMRI Iforia 7 DR-T ICD - Product Status
  • Table 25: ProMRI Iforia 7 DR-T ICD - Product Description
  • Table 26: ProMRI Iforia 7 HF-T ICD - Product Status
  • Table 27: ProMRI Iforia 7 HF-T ICD - Product Description
  • Table 28: ProMRI Iforia 7 VR-T DX ICD - Product Status
  • Table 29: ProMRI Iforia 7 VR-T DX ICD - Product Description
  • Table 30: ProMRI Iforia 7 VR-T ICD - Product Status
  • Table 31: ProMRI Iforia 7 VR-T ICD - Product Description
  • Table 32: Biotronik SE & Co. KG - Ongoing Clinical Trials Overview
  • Table 33: ProMRI Iforia 5 Series DR-T ICD - ProMRI 3T ENHANCED Master Study
  • Table 34: Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 35: Acuity X4 Quad LV Lead - Product Status
  • Table 36: Acuity X4 Quad LV Lead - Product Description
  • Table 37: Autogen X4 CRT-D - Product Status
  • Table 38: Autogen X4 CRT-D - Product Description
  • Table 39: Brady MRI-Safe System - Product Status
  • Table 40: Brady MRI-Safe System - Product Description
  • Table 41: EMBLEM MRI S-ICD System - Product Status
  • Table 42: EMBLEM MRI S-ICD System - Product Description
  • Table 43: EMBLEM S-ICD - Product Status
  • Table 44: EMBLEM S-ICD - Product Description
  • Table 45: ENDOTAK RELIANCE 4-SITE Defibrillation Lead System - Product Status
  • Table 46: ENDOTAK RELIANCE 4-SITE Defibrillation Lead System - Product Description
  • Table 47: HF Multi-Sensor - Product Status
  • Table 48: HF Multi-Sensor - Product Description
  • Table 49: ImageReady Pacing System - Product Status
  • Table 50: ImageReady Pacing System - Product Description
  • Table 51: INGENIO 2 PG - MICS - Product Status
  • Table 52: INGENIO 2 PG - MICS - Product Description
  • Table 53: INGEVITY Pacing Lead - Product Status
  • Table 54: INGEVITY Pacing Lead - Product Description
  • Table 55: MRI Compatible S-ICD - Product Status
  • Table 56: MRI Compatible S-ICD - Product Description
  • Table 57: Next Generation ICD Lead - Product Status
  • Table 58: Next Generation ICD Lead - Product Description
  • Table 59: Next Generation ICD/CRT-D - Product Status
  • Table 60: Next Generation ICD/CRT-D - Product Description
  • Table 61: Next Generation Quad Polar CRT-D - Product Status
  • Table 62: Next Generation Quad Polar CRT-D - Product Description
  • Table 63: NG3 Non Quad System - Product Status
  • Table 64: NG3 Non Quad System - Product Description
  • Table 65: Reliance 4-Front Lead - Product Status
  • Table 66: Reliance 4-Front Lead - Product Description
  • Table 67: S-ICD System 1.5 - Product Status
  • Table 68: S-ICD System 1.5 - Product Description
  • Table 69: S-ICD System 2.0 - Product Status
  • Table 70: S-ICD System 2.0 - Product Description
  • Table 71: Temporary RV VVI pacing - Product Status
  • Table 72: Temporary RV VVI pacing - Product Description
  • Table 73: VITALITY NXT Defibrillator - Product Status
  • Table 74: VITALITY NXT Defibrillator - Product Description
  • Table 75: X4 SYSTEM + QUAD LEAD - Product Status
  • Table 76: X4 SYSTEM + QUAD LEAD - Product Description
  • Table 77: Boston Scientific Corporation - Ongoing Clinical Trials Overview
  • Table 78: ENDOTAK RELIANCE 4-SITE Defibrillation Lead System - Longitudinal Surveillance Study of the 4-SITE Lead/Header System
  • Table 79: INGENIO 2 PG - MICS - Optimizing Pacing Therapy by Using Multi-Programmable Pulse Generators for Cardiac Resynchronization Pacing (CRT-P)
  • Table 80: INGEVITY Pacing Lead - INGEVITY Active Fixation and Passive Fixation Pace/ Sense Lead Clinical Study
  • Table 81: INGEVITY Pacing Lead - INGEVITY Observational Trial: Assessment of Routine Experience and Magnet Resonance Imaging (Mri) Usage with a New Lead for Bradycardia Pacing
  • Table 82: Reliance 4-Front Lead - Evaluation of Acuity X4 Quadripolar Coronary Venous Leads and Reliance 4-Front Defibrillation Leads: NAVIGATE X4
  • Table 83: Reliance 4-Front Lead - Reliance 4-Front Active Fixation Defibrillation Lead Post Market Clinical Follow-Up (PMCF) Study
  • Table 84: Reliance 4-Front Lead - RELIANCE 4-FRONT Passive Fixation Defibrillation Lead Post Market Clinical Follow-Up (PMCF) Study
  • Table 85: Autogen X4 CRT-D - Capture Information Via Automatic Threshold Evaluation
  • Table 86: Acuity X4 Quad LV Lead - Evaluation of Acuity X4 Quadripolar Coronary Venous Leads and Reliance 4-Front Defibrillation Leads: NAVIGATE X4
  • Table 87: Acuity X4 Quad LV Lead - Maximizing CRT Delivery by Using Multipolar Coronary Sinus Lead Family ACUITY X4
  • Table 88: EMBLEM S-ICD - Understanding Outcomes with the EMBLEM S-ICD in Primary Prevention Patients with Low Ejection Fraction
  • Table 89: Boston TransTec, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 90: Raul Pacemaker - Product Status
  • Table 91: Raul Pacemaker - Product Description
  • Table 92: CardiaLen, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 93: CardiaLen Device - Atrial Fibrillation - Product Status
  • Table 94: CardiaLen Device - Atrial Fibrillation - Product Description
  • Table 95: CardiaLen Device - Ventricular Arrhythmia - Product Status
  • Table 96: CardiaLen Device - Ventricular Arrhythmia - Product Description
  • Table 97: CVRx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 98: Barostim neo - Heart Failure - Product Status
  • Table 99: Barostim neo - Heart Failure - Product Description
  • Table 100: CVRx, Inc. - Ongoing Clinical Trials Overview
  • Table 101: Barostim neo - Heart Failure - Baroreflex Activation Therapy for Heart Failure Pivotal Clinical Trial (BeAT-HF)
  • Table 102: Barostim neo - Heart Failure - Baroreflex Activation Therapy in Heart Failure
  • Table 103: Barostim neo - Heart Failure - Barostim HOPE4HF Study
  • Table 104: DHS Medical Pipeline Products & Ongoing Clinical Trials Overview
  • Table 105: Drimmer - Product Status
  • Table 106: Drimmer - Product Description
  • Table 107: Twistek - Product Status
  • Table 108: Twistek - Product Description
  • Table 109: Duke University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 110: Tissue-Engineered Autonomous Pacemaker - Product Status
  • Table 111: Tissue-Engineered Autonomous Pacemaker - Product Description
  • Table 112: EBR Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 113: Second Generation Wireless Pacing System - Product Status
  • Table 114: Second Generation Wireless Pacing System - Product Description
  • Table 115: WiSE System - Product Status
  • Table 116: WiSE System - Product Description

List of Figures

  • Figure 1: Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development
  • Figure 2: Cardiac Rhythm Management Devices - Pipeline Products by Segment
  • Figure 3: Cardiac Rhythm Management Devices - Pipeline Products by Territory
  • Figure 4: Cardiac Rhythm Management Devices - Pipeline Products by Regulatory Path
  • Figure 5: Cardiac Rhythm Management Devices - Pipeline Products by Estimated Approval Date
  • Figure 6: Cardiac Rhythm Management Devices - Ongoing Clinical Trials
Back to Top